Padmanaban, G and Nagaraj, VA (2020) Hydroxychloroquine: A relatively obscure antimalarial takes centre stage in COVID-19. In: Current Science, 118 (10). pp. 1489-1491.
PDF
CUR_SCI_118_10_1489-1491_2020.pdf - Published Version Restricted to Registered users only Download (429kB) | Request a copy |
Official URL: https://www.currentscience.ac.in/Volumes/118/10/14...
Abstract
Hydroxychloroquine (HCQ) is an old antimalarial known for its use to treat rheumatoid arthritis. Recently, it has been shown to be useful in COVID-19 treatment, although its efficacy is being debated and the data from large-scale clinical trials are yet to be available. Overall, it appears that HCQ-Azithromycin-Remdesevir may be a viable treatment option on a case to case basis. There is also a case to evaluate curcumin as an adjunct food supplement to prevent and treat COVID-19. © 2020, Indian Academy of Sciences.
Item Type: | Editorials/Short Communications |
---|---|
Publication: | Current Science |
Publisher: | Indian Academy of Sciences |
Additional Information: | Copy right for this article belongs to Indian Academy of Sciences |
Department/Centre: | Division of Biological Sciences > Biochemistry |
Date Deposited: | 11 Nov 2020 10:52 |
Last Modified: | 11 Dec 2022 04:43 |
URI: | https://eprints.iisc.ac.in/id/eprint/65724 |
Actions (login required)
View Item |